EFFICACY OF LY2951742 IN SUBGROUPS OF PATIENTS WITH MIGRAINE OF DIFFERENT FREQUENCY

被引：0
|
作者：
Skljarevski, V. [1 ]
Martinez, J. [1 ]
Oakes, T. [1 ]
Ferguson, M. [2 ]
Tanaka, Y. [3 ]
Due, M. [4 ]
Schacht, A. [5 ]
机构：
[1] Eli Lilly & Co, Pain Team Med, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, Clin Operat, Scarborough, ON, Canada
[3] Eli Lilly & Co, RWA Capabil & Datamart, Indianapolis, IN 46285 USA
[4] Eli Lilly & Co, Global Sci Commun, Indianapolis, IN 46285 USA
[5] Eli Lilly & Co, Elanco, Indianapolis, IN 46285 USA
来源：
CEPHALALGIA | 2016年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EHMTC-0111
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [41] Safety, pharmacokinetics and preliminary efficacy data of LY334370, a novel SSOFRA, in patients with acute migraine.
    Granier, LA
    Vandenhende, F
    de Suray, JM
    Gossen, D
    Stassen, N
    Onkelinx, C
    CEPHALALGIA, 1999, 19 (04) : 367 - 367
  • [42] Visual evoked potentials in subgroups of migraine with aura patients
    Gianluca Coppola
    Martina Bracaglia
    Davide Di Lenola
    Cherubino Di Lorenzo
    Mariano Serrao
    Vincenzo Parisi
    Antonio Di Renzo
    Francesco Martelli
    Antonello Fadda
    Jean Schoenen
    Francesco Pierelli
    The Journal of Headache and Pain, 2015, 16
  • [43] Visual evoked potentials in subgroups of migraine with aura patients
    Coppola, Gianluca
    Bracaglia, Martina
    Di Lenola, Davide
    Di Lorenzo, Cherubino
    Serrao, Mariano
    Parisi, Vincenzo
    Di Renzo, Antonio
    Martelli, Francesco
    Fadda, Antonello
    Schoenen, Jean
    Pierelli, Francesco
    JOURNAL OF HEADACHE AND PAIN, 2015, 16
  • [44] FREQUENCY OF DEPRESSION IN MIGRAINE PATIENTS
    Bhurgri, Ghulam Rasool
    Buksh, Hussain
    Qureshi, Muhammad Ali
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2009, 7 (02): : 106 - 108
  • [45] Clinical features of right-to-left shunt in the different subgroups of migraine
    Ling, Yanyan
    Wang, Min
    Pan, Xudong
    Zhao, Hongqin
    BRAIN AND BEHAVIOR, 2020, 10 (03):
  • [46] Reductions in Migraine Frequency with Fremanezumab Treatment by Baseline Migraine Frequency Category in Patients with Chronic and Episodic Migraine
    Nahas, Stephanie J.
    Ning, Xiaoping
    Cohen, Joshua M.
    Barash, Steve
    Campos, Verena Ramirez
    Carr, Karen
    Silberstein, Stephen D.
    ANNALS OF NEUROLOGY, 2021, 90 : S133 - S134
  • [47] The impact of onabotulinumtoxinA vs placebo on efficacy outcomes in responder and nonresponder subgroups of patients with chronic migraine: PREEMPT pooled analysis
    Diener, H-C.
    Lipton, R.
    Dodick, D. W.
    Degryse, R. E.
    Adams, A.
    Silberstein, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 426 - 426
  • [48] The Impact of OnabotulinumtoxinA vs Placebo on Efficacy Outcomes in Responder and Nonresponder Subgroups of Patients with Chronic Migraine: PREEMPT Pooled Analysis
    Diener, H.
    Lipton, R. B.
    Dodick, D. W.
    DeGryse, R.
    Adams, A. Manack
    Silberstein, S. D.
    HEADACHE, 2019, 59 : 35 - 35
  • [49] The impact of onabotulinumtoxinA vs placebo on efficacy outcomes in responder and nonresponder subgroups of patients with chronic migraine: PREEMPT pooled analysis
    Diener, Hans-Christoph
    Lipton, Richard B.
    Dodick, David W.
    DeGryse, Ronald E.
    Adams, Aubrey Manack
    Silberstein, Stephen
    CEPHALALGIA, 2019, 39 : 260 - 261
  • [50] Efficacy of topiramate in the prophylaxis of high frequency migraine in children
    Singh, NN
    Misra, S
    CEPHALALGIA, 2003, 23 (07) : 723 - 723
12345